The mitochondrial Uncoupling Protein 2 UCP2 is a member of the mitochondrial carrier family and belongs to the UCP subfamily. It is widely expressed in tissues. In immune cells, UCP2 has a regulatory function through its effect on the production of reactive oxygen species and MAPK signalling. Ucp2 −/− mice are resistant to infection by parasites and intracellular bacteria but are more sensitive to chronic inflammation and experimental neurodegeneration. We found that autoimmune diabetes was strongly accelerated in Ucp2 −/− mice compared to Ucp2 +/+ mice with increased intra-islet lymphocytic infiltration. These data highlight UCP2 as a new player in autoimmune diabetes. In addition, in agreement with the known inhibitory role of UCP2 on insulin secretion, loss of function of UCP2 contributes to congenital hyperinsulinism in patients. . This favours the release of superoxide anion, which initiates the transcriptional activation of NF-κB as an early stress signalling response. We have recently used this technique to demonstrate that NO is inactivated by cytochrome c oxidase in its oxidised state and that cessation of such inactivation at low [O 2 ] may account for hypoxic vasodilatation. Many cells respond to a decrease in oxygen availability via stabilisation of hypoxia-inducible factor-1α (HIF-1α), whose accumulation is normally prevented by the action of prolyl hydroxylases. We have found that inhibition of mitochondrial respiration by low concentrations of NO leads to inhibition of HIF-1α stabilisation. This prevents the cell from registering a state of hypoxia at low [O 2 ], which would otherwise result in upregulation of defensive genes associated with, for example, glycolysis and angiogenesis. Furthermore, upon inhibition of mitochondrial respiration in hypoxia, oxygen is redistributed toward non-respiratory oxygen-dependent targets.
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Our results demonstrate that NO acts not only as a physiological regulator of cell respiration but also as a signalling agent in the mitochondria and a controller of the distribution of available oxygen. Such mechanisms may also be involved in the initiation of pathophysiology. A concept is developed considering aging as an evolutionfacilitating program which is unnecessary and counterproductive for human and, therefore, should be arrested. To do this, an attempt is undertaken to inactive mitochondria-produced reactive oxygen species (ROS) which seem to mediate execution of the aging program. We synthesized mitochondria-targeted, rechargeable, hydrophobic antioxidant composed of plastoquinone and cation of decyltriphenylphosphonium (SkQ1). It is shown that very low (nmol/kg/day) amounts of SkQ1 increase the lifespan of a fungus (Podospora anserine), invertebrates (Ceriodaphnia affinis and Drosophila melanogaster) and a mammal (mouse). Even more important, in mice SkQ1 abrogates development of such typical traits of senescence as osteoporosis (kyphosis), decrease in resistance to infections, depression, alopecia, loss of whiskers, gray hairs, disappearance of regular oestrous cycles, etc. In rats, pretreatment with SkQ1 or its homolog, SkQR1, has favourable effect in the cases of experimental heart arrhythmia, heart and kidney infarction or stroke. In rats, rabbits, cats, dogs and horses, drops of 250 nM SkQ1 prevent development of certain types of cataract, retinopathies and uveitis and in some cases return vision to animals that became blind due to these pathologies. These data are consistent with the assumption that SkQ1 interferes with execution of aging program and is promising in treating some agerelated diseases.
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